ICPT shares rise after patent settlement with Amneal (NASDAQ:ICPT)

Gratitude Concept With Heart Icon


Shares of Intercept Pharmaceuticals (NASDAQ:ICPT) added ~8% on Wednesday after biotech announced an agreement with generic drugmaker Amneal Pharmaceuticals (NYSE:AMRX) to settle a patent dispute over the Ocaliva liver disease therapy.

The January 24 agreement to settle a


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button